Latest Clinical cardiac electrophysiology Stories
New research presented at National Heart Rhythm Society Sessions shows ablation treatment can eliminate serious risks associated with atrial fibrillationNew findings by researchers from the Heart Institute at Intermountain Medical Center in Murray, Utah, reveals treatment of the most common heart rhythm disorder that affects more than two million Americans significantly reduces the risk of stroke, mortality, Alzheimer's disease and other forms of dementia.According to two new studies by the...
DIAMOND BAR, California, May 13, 2010 /PRNewswire/ -- Biosense Webster, Inc. will underline its leadership position in the electrophysiology market and underscore its commitment to electrophysiologists and their catheter ablation practices at the 2010 Heart Rhythm Meeting. Heart Rhythm is the most important scientific meeting in the field of Electrophysiology and will be held in Denver, CO, USA from May 12th to 15th. This year, Biosense Webster, Inc. will be showcasing its cutting...
RALEIGH, N.C., May 13 /PRNewswire/ -- nContact Surgical, Inc. (nContact) announced it has enrolled the first patient in its IDE trials to evaluate a fully closed chest procedure combining the best of Electrophysiologist (EP) catheter and surgical techniques for the treatment of atrial fibrillation (AF) using the investigational Numeris® - AF Guided Coagulation System with VisiTrax®. The three hour procedure is performed in a single setting, generally in the EP Lab, by both...
WALTHAM, Mass., April 21 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, specialty radiofrequency catheters will drive growth in the European catheter market and support the use of catheter ablation as a treatment for atrial fibrillation. According to MRG's new European Markets for Electrophysiology Mapping and Ablation Devices 2010 report, specialty radiofrequency ablation catheter use will grow at a compound...
MORRISVILLE, N.C., April 19 /PRNewswire/ -- nContact Surgical, Inc ("nContact") today announced it has received the first Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to evaluate the safety and efficacy of a combined surgical and catheter procedure (the convergent procedure) to treat patients with longstanding persistent atrial fibrillation (AF). nContact's Numeris®-AF Guided Coagulation System with VisiTrax® will be used in combination with...
Use of catheter ablation, in which radiofrequency energy is emitted from a catheter to eliminate the source of an irregular heartbeat, resulted in significantly better outcomes in patients with paroxysmal atrial fibrillation (intermittent cardiac rhythm disturbance) who had not responded previously to antiarrhythmic drug therapy, according to a study in the January 27 issue of JAMA.Atrial fibrillation (AF) represents an important public health problem, with patients having an increased...
NEW YORK, Nov. 17 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. European Market for Cardiac Rhythm Management, Electrophysiology, and Ablation Devices 2009 (15 Countries) http://www.reportlinker.com/p0164177/European-Market-for-Cardiac-Rhythm-Management-Electrophysiology-and-Ablation-Devices-2009-(15-Countries).html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire In 2008, the market for cardiac rhythm...
Only Hospital in Northern and Central California to Reach 1,000 A-Fib Ablations REDWOOD CITY, Calif., Sept. 8 /PRNewswire-USNewswire/ -- Sequoia Hospital announced that the Cardiac Arrhythmia Program has completed 1,000 atrial fibrillation (A-Fib) ablation procedures, making it the highest total volume A-Fib ablation institution currently performing ablations in Northern and Central California. Numerous medical journals and world-wide ablation center surveys have documented that this type...
Clinical Specialists Provide Feedback on Current and Future Trends MOUNTAIN VIEW, Calif., June 8 /PRNewswire/ -- A recent Frost & Sullivan end-user survey shows increased awareness and utilization of new tools and approaches to treating atrial fibrillation (Afib). Of the various forms of cardiac arrhythmia, AFib is the one of the most prevalent and hardest to treat. Two and a half million people in the U.S. have AFib, and about one million are symptomatic and do not respond well to...
 A new innovative approach to treating atrial fibrillation (A-Fib) is showing improved results over the common drug treatment.Over 2 million Americans suffer from A-fib, a disorder which in which the heart beats irregularly due to quivering in the upper chambers of the heart. Clots form when not all of the blood is able to be pumped out, which may also lead to strokes and heart failure.While drugs may be able to slow the heart rate or assist in maintaining the rhythm, in the study of 167...
